A Randomized Double-Blind, Placebo-Controlled, 4-Period Cross-Over Study to Assess the Effect of Single and Multiple Doses of 1.5 mg and 4.5 mg Org 50081 and a Single Dose of 7.5 mg Zopiclone on Next-Day Driving Ability and Psychomotor Performance in Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 30 Sep 2013
At a glance
- Drugs Esmirtazapine; Zopiclone
- Indications Mental disorders; Sleep disorders
- Focus Pharmacodynamics
- Sponsors Organon
- 03 Dec 2008 New trial record.